Survey of Ophthalmology
Volume 49, Issue 4 , Pages 399-418 , July 2004

Ocular manifestations and concepts of systemic vasculitides

References 

  1. Abbas AK, Perez VL, Van Parijs L, Wong RC. Differentiation and tolerance of CD4+ T lymphocytes. Ciba Found Symp. 1995;195:7–13 discussion 13–9
  2. Abel G, Zhang QX, Agnello V. Hepatitis C virus infection in type II mixed cryoglobulinemia. Arthritis Rheum. 1993;36:1341–1349
  3. Acheson JF, Cockerell OC, Bentley CR, Sanders MD. Churg-Strauss vasculitis presenting with severe visual loss due to bilateral sequential optic neuropathy. Br J Ophthalmol. 1993;77:118–119
  4. Adu D, Pall A, Luqmani RA, et al.  Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis. QJM. 1997;90:401–409
  5. Agnello V, Romain PL. Mixed cryoglobulinemia secondary to hepatitis C virus infection. Rheum Dis Clin North Am. 1996;22:1–21
  6. Akova YA, Jabbur NS, Foster CS. Ocular presentation of polyarteritis nodosa. Clinical course and management with steroid and cytotoxic therapy. Ophthalmology. 1993;100:1775–1781
  7. Allen DM, Diamond LK, Howell DA. Anaphylactoid purpura in children (Schönlein-Henoch syndrome). Am J Dis Child. 1960;99:833–854
  8. Andersson R, Malmvall BE, Bengtsson BA. Acute phase reactants in the initial phase of giant cell arteritis. Acta Med Scand. 1986;220:365–367
  9. Ashton N, Cook C. Allergic granulomatous nodules of the eyelid and conjunctiva. The XXXV Edward Jackson Memorial Lecture. Am J Ophthalmol. 1979;87:1–28
  10. Austin P, Green WR, Sallyer DC, et al.  Peripheral corneal degeneration and occlusive vasculitis in Wegener's granulomatosis. Am J Ophthalmol. 1978;85:311–317
  11. Azar N, Guillevin L, Huong Du LT, et al.  Symptomatic urogenital manifestations of polyarteritis nodosa and Churg-Strauss angiitis: analysis of 8 of 165 patients. J Urol. 1989;142:136–138
  12. Baldassano VF. Ocular manifestations of rheumatic diseases. Curr Opin Ophthalmol. 1998;9:85–88
  13. Barchuk WT, Centeno L, Frohman L, Bielory L. Immunology and ocular manifestations of giant cell arteritis. Ocul Immunol Inflamm. 1997;5:141–146
  14. Barron KS. Kawasaki disease in children. Curr Opin Rheumatol. 1998;10:29–37
  15. Bawazeer AM, Jackson WB. Marginal infiltrative ulcerative keratitis secondary to Churg-Strauss syndrome: a case report. Cornea. 2000;19:402–404
  16. Bengtsson BA, Malmvall BE. Giant cell arteritis. Acta Med Scand. 1982;208(Suppl):658
  17. Ben-Smith A, Dove SK, Martin A, et al.  Antineutrophil cytoplasm autoantibodies from patients with systemic vasculitis activate neutrophils through distinct signaling cascades: comparison with conventional Fcgamma receptor ligation. Blood. 2001;98:1448–1455
  18. Bligard CA. Kawasaki disease and its diagnosis. Pediatr Dermatol. 1987;4:75–84
  19. Boeck J. Ocular changes in periarteritis nodosa. Am J Ophthalmol. 1956;42:567–576
  20. Bosch-Gil JA, Falgà-Tirado C, Simeón-Aznar CP, Orriols-Martı́nez R. Churg-Strauss syndrome with inflammatory orbital pseudotumour. Br J Rheumatol. 1995;34:485–486
  21. Bredvik BK, Trocme SD. Ocular manifestations of immunological and rheumatological inflammatory disorders. Curr Opin Ophthalmol. 1995;6:92–96
  22. Brittain GP, McIlwaine GG, Bell JA, Gibson JM. Plasma viscosity or erythrocyte sedimentation rate in the diagnosis of giant cell arteritis?. Br J Ophthalmol. 1991;75:656–659
  23. Bullen CL, Liesegang TJ, McDonald TJ, DeRemee RA. Ocular complications of Wegener's granulomatosis. Ophthalmology. 1983;90:279–290
  24. Burns JC, Mason WH, Glode MP, et al.  Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. J Pediatr. 1991;118:680–686
  25. Caster JC, Shetlar DJ, Pappolla MA, Yee RW. Microscopic polyangiitis with ocular involvement. Arch Ophthalmol. 1996;114:346–348
  26. Chakravarty K, Pountain G, Merry P, et al.  A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis. J Rheumatol. 1995;22:1694–1697
  27. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med. 1982;97:672–680
  28. Chumbley LC, Harrison EG, DeRemee RA. Allergic granulomatosis and angiitis (Churg-Strauss syndrome). Report and analysis of 30 cases. Mayo Clin Proc. 1977;52:477–484
  29. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis and periarteritis nodosa. Am J Pathol. 1951;27:277–301
  30. Cohen SM, Kokame GT, Gass JD. Paraproteinemias associated with serous detachments of the retinal pigment epithelium and neurosensory retina. Retina. 1996;16:467–473
  31. Conn DL. Polyarteritis. Rheum Dis Clin North Am. 1990;16:341–362
  32. Coombs RRA, Gell PGH. The classification of allergic reactions underlying disease. In:  Gell PGH,  Coombs RRA editor. Clinical Aspects of Immunology. Philadelphia: Davis; 1963;p. 317
  33. Corwin JM, Baum J. Iridocyclitis in two patients with hypocomplementemic cutaneous vasculitis. Am J Ophthalmol. 1982;94:111–113
  34. Cury B, Breakey AS, Payne BF. Allergic granulomatous angiitis associated with uveoscleritis and papilledema. Arch Ophthalmol. 1966;55:261–266
  35. Dagi LR, Currie J. Branch retinal artery occlusion in the Churg-Strauss syndrome. J Clin Neuroophthalmol. 1985;5:229–237
  36. D'Amico G, Fornasieri A. Cryoglobulinemic glomerulonephritis: a membranoproliferative glomerulonephritis induced by hepatitis C virus. Am J Kidney Dis. 1995;25:361–369
  37. Davson J, Ball J, Platt R. The kidney in periarteritis nodosa. Q J Med. 1948;17:175
  38. de Groot K, Gross WL. Wegener's granulomatosis: disease course, assessment of activity and extent and treatment. Lupus. 1998;7:285–291
  39. de Groot K, Mühler M, Reinhold-Keller E, et al.  Induction of remission in Wegener's granulomatosis with low dose methotrexate. J Rheumatol. 1998;25:492–495
  40. Del Buono EA, Flint A. Diagnostic usefulness of nasal biopsy in Wegener's granulomatosis. Hum Pathol. 1991;22:107–110
  41. Devaney KO, Travis WD, Hoffman G, et al.  Interpretation of head and neck biopsies in Wegener's granulomatosis. A pathologic study of 126 biopsies in 70 patients. Am J Surg Pathol. 1990;14:555–564
  42. Duhaut P, Berruyer M, Pinede L, et al.  Anticardiolipin antibodies and giant cell arteritis: a prospective, multicenter case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes. Arthritis Rheum. 1998;41:701–709
  43. Ellis ME, Ralston S. The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome. Ann Rheum Dis. 1983;42:168–170
  44. Eshaghian J, Goeken JA. C-reactive protein in giant cell (cranial, temporal) arteritis. Ophthalmology. 1980;87:1160–1166
  45. Espinoza LR, Jara LJ, Silveira LH, et al.  Anticardiolipin antibodies in polymyalgia rheumatica-giant cell arteritis: association with severe vascular complications. Am J Med. 1991;90:474–478
  46. Ewert BH, Jennette JC, Falk RJ. Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kidney Int. 1992;41:373–383
  47. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983;98:76–85
  48. Ferri C, Greco F, Longombardo G, et al.  Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum. 1991;34:1606–1610
  49. Ferri C, La Civita L, Longombardo G, et al.  Hepatitis C virus and mixed cryoglobulinaemia. Eur J Clin Invest. 1993;23:399–405
  50. Font RL, Mehta RS, Streusand SB, et al.  Bilateral retinal ischemia in Kawasaki disease. Postmortem findings and electron microscopic observations. Ophthalmology. 1983;90:569–577
  51. Ford RG, Siekert RG. Central nervous system manifestations of periarteritis nodosa. Neurology. 1965;15:114–122
  52. Foster CS. Ocular manifestations of the nonrheumatic acquired collagen vascular diseases. In:  Smolin G,  Thoft RA editor. The Cornea: Scientific Foundations and Clinical Practice. ed 2. Boston, Little: Brown; 1987;p. 352–357
  53. Foster CS. Immunosuppressive therapy for external ocular inflammatory disease. Ophthalmology. 1980;87:140–150
  54. Francès C, Boisnic S, Blétry O, et al.  Cutaneous manifestations of Takayasu arteritis. A retrospective study of 80 cases. Dermatologica. 1990;181:266–272
  55. Frohnert PP, Sheps SG. Long-term follow-up study of periarteritis nodosa. Am J Med. 1967;43:8–14
  56. Ghanchi FD, Dutton GN. Current concepts in giant cell (temporal) arteritis. Surv Ophthalmol. 1997;42:99–123
  57. Goldsmith J. Periarteritis nodosa with involvement of the choroidal and retinal arteries. Am J Ophthalmol. 1946;29:435–446
  58. Goodman BW. Temporal arteritis. Am J Med. 1979;67:839–852
  59. Gorevic PD, Frangione B. Mixed cryoglobulinemia cross-reactive idiotypes: implications for the relationship of MC to rheumatic and lymphoproliferative diseases. Semin Hematol. 1991;28:79–94
  60. Greenberger MH. Central retinal artery closure in Wegener's granulomatosis. Am J Ophthalmol. 1967;63:515–516
  61. Gross WL. Immunopathogenesis of vasculitis. In:  Klippel JH,  Dieppe PA editor. Rheumatology. London and Philadelphie: Mosby; 1998;p. 19.1–19.8
  62. Gross WL, Csernok E. Immunodiagnostic and pathophysiologic aspects of antineutrophil cytoplasmic antibodies in vasculitis. Curr Opin Rheumatol. 1995;7:11–19
  63. Gross WL, Trabandt A, Reinhold-Keller E. Diagnosis and evaluation of vasculitis. Rheumatology (Oxford). 2000;39:245–252
  64. Gudmundsson M, Nordborg E, Bengtsson BA, Bjelle A. Plasma viscosity in giant cell arteritis as a predictor of disease activity. Ann Rheum Dis. 1993;52:104–109
  65. Guillevin L, Lhote F, Jarrousse B. Treatment of polyarteritis nodosa and Churg-Strauss syndrome. A meta-analysis of three prospective controlled trials including 182 patients over 12 years. Ann Med Interne (Paris). 1992;143:405–416
  66. Guillevin L, Visser H, Noel LH, et al.  Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome—62 patients. J Rheumatol. 1993;20:1345–1349
  67. Hagen EC, Daha MR, Hermans J, et al.  Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int. 1998;53:743–753
  68. Harper L, Cockwell P, Adu D, Savage CO. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Kidney Int. 2001;59:1729–1738
  69. Haynes BF, Fishman ML, Fauci AS, Wolff SM. The ocular manifestations of Wegener's granulomatosis. Fifteen years experience and review of the literature. Am J Med. 1977;63:131–141
  70. Hayreh SS, Podhajsky PA, Zimmerman B. Ocular manifestations of giant cell arteritis. Am J Ophthalmol. 1998;125:509–520
  71. Hayreh SS, Podhajsky PA, Zimmerman B. Occult giant cell arteritis: ocular manifestations. Am J Ophthalmol. 1998;125:521–526
  72. Heberden W: Commentarii di morborium historia et curatione. London: Payne, 1801. Reprinted as “Commentaries on the history and cure of diseases” Birmingham, Alabama: The Classics of Medicine Library, Division of Gryphon Editions, Ltd, 1982, pp 395–7.
  73. Hoffman GS, Kerr GS, Leavitt RY, et al.  Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992;116:488–498
  74. Hoffman GS, Leavitt RY, Fleisher TA, et al.  Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide. Am J Med. 1990;89:403–410
  75. Hoffman GS, Leavitt RY, Kerr GS, Fauci AS. The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate. Arthritis Rheum. 1992;35:1322–1329
  76. Hoffman GS, Leavitt RY, Kerr GS, et al.  Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum. 1994;37:578–582
  77. Holds JB, Anderson RL, Wolin MJ. Dacryocystectomy for the treatment of dacryocystitis patients with Wegener's granulomatosis. Ophthalmic Surg. 1989;20:443–444
  78. Horwitz JA, Worthen DM. Episcleral nodule in systemic vasculitis. Ann Ophthalmol. 1972;4:482–483
  79. Hunder GG, Arend WP, Bloch DA, et al.  The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum. 1990;33:1065–1067
  80. Huston KA, Hunder GG, Lie JT, et al.  Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med. 1978;88:162–167
  81. Jaben SL, Norton EW. Exudative retinal detachment in Wegener's granulomatosis: case report. Ann Ophthalmol. 1982;14:717–720
  82. Jacob JL, Polomeno RC, Chad Z, Lapointe N. Ocular manifestations of Kawasaki disease (mucocutaneous lymph node syndrome). Can J Ophthalmol. 1982;17:199–202
  83. Jacobson DM, Slamovits TL. Erythrocyte sedimentation rate and its relationship to hematocrit in giant cell arteritis. Arch Ophthalmol. 1987;105:965–967
  84. Jayne DR, Lockwood CM. Pooled intravenous immunoglobulin in the management of systemic vasculitis. Adv Exp Med Biol. 1993;336:469–472
  85. Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med. 1997;337:1512–1523
  86. Jennette JC, Falk RJ, Andrassy K, et al.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37:187–192
  87. Jonasson F, Cullen JF, Elton RA. Temporal arteritis. A 14-year epidemiological, clinical and prognostic study. Scott Med J. 1979;24:111–117
  88. Jordan DR, Addison DJ. Wegener's granulomatosis. Eyelid and conjunctival manifestations as the presenting feature in two individuals. Ophthalmology. 1994;101:602–607
  89. Karam EZ, Muci-Mendoza R, Hedges TR. Retinal findings in Takayasu's arteritis. Acta Ophthalmol Scand. 1999;77:209–213
  90. Kato H, Ichinose E, Kawasaki T. Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases. J Pediatr. 1986;108:923–927
  91. Kattah JC, Chrousos GA, Katz PA, et al.  Anterior ischemic optic neuropathy in Churg-Strauss syndrome. Neurology. 1994;44:2200–2202
  92. Kaufman AH, Niles JL, Foster CS. ANCA test in ophthalmic inflammatory disease. Int Ophthalmol Clin. 1994;34:215–227
  93. Kerr GS, Hallahan CW, Giordano J, et al.  Takayasu arteritis. Ann Intern Med. 1994;120:919–929
  94. Kimbrell OC, Wheliss JA. Polyarteritis nodosa complicated by bilateral optic neuropathy. JAMA. 1967;201:139–140
  95. Kitay-Cohen Y, Amiel A, Hilzenrat N, et al.  Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type II. Blood. 2000;96:2910–2912
  96. Kiyosawa M, Baba T. Ophthalmological findings in patients with Takayasu disease. Int J Cardiol. 1998;66(Suppl 1):S141–S147 discussion S149
  97. Klein RG, Hunder GG, Stanson AW, Sheps SG. Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med. 1975;83:806–812
  98. Klien BA. Ischemic infarcts of the choroid (Elschinig spots). A cause of retinal separation in hypertensive disease with renal insufficiency. A clinical and histopathologic study. Am J Ophthalmol. 1968;66:1069–1074
  99. Kopstein AB, Kristopaitis T, Gujrati TM, et al.  Orbital Wegener granulomatosis without systemic findings. Ophthal Plast Reconstr Surg. 1999;15:467–469
  100. Koyama T, Matsuo N, Watanabe Y, et al.  Wegener's granulomatosis with destructive ocular manifestations. Am J Ophthalmol. 1984;98:736–740
  101. Kremer I, Blumenthal M. Excimer phototherapeutic keratectomy for corneal subepithelial cryoglobulin deposits. J Cataract Refract Surg. 1997;23:1119–1121
  102. Kremer I, Wright P, Merin S, et al.  Corneal subepithelial monoclonal kappa IgG deposits in essential cryoglobulinaemia. Br J Ophthalmol. 1989;73:669–673
  103. Kyle V, Cawston TE, Hazleman BL. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis. 1989;48:667–671
  104. Lai R, Weiss LM. Hepatitis C virus and non-Hodgkin's lymphoma. Am J Clin Pathol. 1998;109:508–510
  105. Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore). 1984;63:65–81
  106. Leavitt RY, Fauci AS, Bloch DA, et al.  The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 1990;33:1101–1107
  107. Lhote F, Cohen P, Généreau T, et al.  Microscopic polyangiitis: clinical aspects and treatment. Ann Med Interne (Paris). 1996;147:165–177
  108. Lhote F, Guillevin L. Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome. Clinical aspects and treatment. Rheum Dis Clin North Am. 1995;21:911–947
  109. Lightfoot RW, Michel BA, Bloch DA, et al.  The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum. 1990;33:1088–1093
  110. Lin H, Burton EM, Felz MW. Orbital myositis due to Kawasaki's disease. Pediatr Radiol. 1999;29:634–636
  111. Liu GT, Glaser JS, Schatz NJ, Smith JL. Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision. Ophthalmology. 1994;101:1779–1785
  112. Lorentz WB, Weaver RG. Eye involvement in anaphylactoid purpura. Am J Dis Child. 1980;134:524–525
  113. Love DC, Rapkin J, Lesser GR, et al.  Temporal arteritis in blacks. Ann Intern Med. 1986;105:387–389
  114. Lüdemann G, Gross WL. Autoantibodies against cytoplasmic structures of neutrophil granulocytes in Wegener's granulomatosis. Clin Exp Immunol. 1987;69:350–357
  115. Malmvall BE, Bengtsson BA. Giant cell arteritis. Clinical features and involvement of different organs. Scand J Rheumatol. 1978;7:154–158
  116. Mandl LA, Solomon DH, Smith EL, et al.  Using antineutrophil cytoplasmic antibody testing to diagnose vasculitis: can test-ordering guidelines improve diagnostic accuracy?. Arch Intern Med. 2002;162:1509–1514
  117. Mauriello JA, Stabile C, Wagner RS. Dacryocystitis following Kawasaki's disease. Ophthal Plast Reconstr Surg. 1986;2:209–211
  118. McLean RM, Greco TP. Anticardiolipin antibodies in the polymyalgia rheumatica-temporal arteritis syndromes. Clin Rheumatol. 1995;14:191–196
  119. Meisler DM, Stock EL, Wertz RD, et al.  Conjunctival inflammation and amyloidosis in allergic granulomatosis and angiitis (Churg-Strauss syndrome). Am J Ophthalmol. 1981;91:216–219
  120. Messmer EM, Foster CS. Vasculitic peripheral ulcerative keratitis. Surv Ophthalmol. 1999;43:379–396
  121. In:  Miller NR,  Newman NJ editor. Walsh and Hoyt's Clinical Neuro-Ophthalmology. ed 5. Baltimore: William and Wilkins; 1997;p. 375–376
  122. Monteverde A, Rivano MT, Allegra GC, et al.  Essential mixed cryoglobulinemia, type II: a manifestation of a low-grade malignant lymphoma? Clinical-morphological study of 12 cases with special reference to immunohistochemical findings in liver frozen sections. Acta Haematol. 1988;79:20–25
  123. Monteverde A, Sabattini E, Poggi S, et al.  Bone marrow findings further support the hypothesis that essential mixed cryoglobulinemia type II is characterized by a monoclonal B-cell proliferation. Leuk Lymphoma. 1995;20:119–124
  124. Morgan CM, Foster CS, D'Amico DJ, Gragoudas ES. Retinal vasculitis in polyarteritis nodosa. Retina. 1986;6:205–209
  125. Moyana TN. Necrotizing arteritis of the vermiform appendix. A clinicopathologic study of 12 cases. Arch Pathol Lab Med. 1988;112:738–741
  126. Myers JP, Di Bisceglie AM, Mann ES. Cryoglobulinemia associated with Purtscher-like retinopathy. Am J Ophthalmol. 2001;131:802–804
  127. Newburger JW, Takahashi M, Burns JC, et al.  The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986;315:341–347
  128. Newman NJ, Slamovits TL, Friedland S, Wilson WB. Neuro-ophthalmic manifestations of meningocerebral inflammation from the limited form of Wegener's granulomatosis. Am J Ophthalmol. 1995;120:613–621
  129. Newman NM, Hoyt WF, Spencer WH. Macula-sparing monocular blackouts. Clinical and pathologic investigations of intermittent choroidal vascular insufficiency in a case of periarteritis nodosa. Arch Ophthalmol. 1974;91:367–370
  130. Nishino H, Rubino FA. Horner's syndrome in Wegener's granulomatosis: report of four cases. J Neurol Neurosurg Psychiatry. 1993;56:897–899
  131. Nishino H, Rubino FA, DeRemee RA, et al.  Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol. 1993;33:4–9
  132. Nissim F, Von der Valde J, Czernobilsky B. A limited form of Churg-Strauss syndrome: ocular and cutaneous manifestations. Arch Pathol Lab Med. 1982;106:305–307
  133. Nordborg E, Bengtsson BA. Epidemiology of biopsy-proven giant cell arteritis (GCA). J Intern Med. 1990;227:233–236
  134. Nordborg E, Nordborg C, Malmvall BE, et al.  Giant cell arteritis. Rheum Dis Clin North Am. 1995;21:1013–1026
  135. Ohno S, Miyajima T, Higuchi M, et al.  Ocular manifestations of Kawasaki's disease (mucocutaneous lymph node syndrome). Am J Ophthalmol. 1982;93:713–717
  136. Park JR, Jones JG, Hazleman BL. Relationship of the erythrocyte sedimentation rate to acute phase proteins in polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis. 1981;40:493–495
  137. Piette JC, Bourgault I, Legrain S, et al.  Systemic polyarteritis nodosa diagnosed at hysterectomy. Am J Med. 1987;82:836–838
  138. Pinchoff BS, Spahlinger DA, Bergstrom TJ, Sandall GS. Extraocular muscle involvement in Wegener's granulomatosis. J Clin Neuroophthalmol. 1983;3:163–168
  139. Poole TR, Graham EM. Ocular manifestations of rheumatologic disorders. Curr Opin Ophthalmol. 1999;10:458–463
  140. Pountain GD, Calvin J, Hazleman BL. Alpha 1-antichymotrypsin, C-reactive protein and erythrocyte sedimentation rate in polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol. 1994;33:550–554
  141. Power WJ, Rodriguez A, Neves RA, et al.  Disease relapse in patients with ocular manifestations of Wegener granulomatosis. Ophthalmology. 1995;102:154–160
  142. Praprotnik S, Rozman B, Blank M, Shoenfeld Y. Pathogenic role of anti-endothelial cell antibodies in systemic vasculitis. Wien Klin Wochenschr. 2000;112:660–664
  143. Purcell JJ, Birkenkamp R, Tsai CC. Conjunctival lesions in periarteritis nodosa. A clinical and immunopathologic study. Arch Ophthalmol. 1984;102:736–738
  144. Rao JK, Weinberger M, Oddone EZ, et al.  The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis. Ann Intern Med. 1995;123:925–932
  145. Regan CD, Foster CS. Retinal vascular diseases: clinical presentation and diagnosis. Int Ophthalmol Clin. 1986;26:25–53
  146. Remigio P, Zaino E. Polyarteritis nodosa of the gallbladder. Surgery. 1970;67:427–431
  147. Renaldini E, Spandrio S, Cerudelli B, et al.  Cardiac involvement in Churg-Strauss syndrome: a follow-up of three cases. Eur Heart J. 1993;14:1712–1716
  148. Rose GA. The natural history of polyarteritis nodosa. Br Med J. 1957;2:1148–1152
  149. Rosen ES. The retinopathy in polyarteritis nodosa. Br J Ophthalmol. 1968;52:903–906
  150. Sale S, Patterson R. Recurrent Churg-Strauss vasculitis. With exophthalmos, hearing loss, nasal obstruction, amyloid deposits, hyperimmunoglobulinemia E, and circulating immune complexes. Arch Intern Med. 1981;141:1363–1365
  151. Saulsbury FT. Henoch-Schönlein purpura. Curr Opin Rheumatol. 2001;13:35–40
  152. Saulsbury FT. Henoch-Schönlein purpura in children. Report of 100 patients and review of the literature. Medicine (Baltimore). 1999;78:395–409
  153. Savage CO, Winearls CG, Evans DJ, et al.  Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med. 1985;56:467–483
  154. Schmidt MH, Fox AJ, Nicolle DA. Bilateral anterior ischemic optic neuropathy as a presentation of Takayasu's disease. J Neuroophthalmol. 1997;17:156–161
  155. Sharma S, Kamalakar T, Rajani M, et al.  The incidence and patterns of pulmonary artery involvement in Takayasu's arteritis. Clin Radiol. 1990;42:177–181
  156. Sheard RM, Pandey KR, Barnes ND, Vivian AJ. Kawasaki disease presenting as orbital cellulitis. J Pediatr Ophthalmol Strabismus. 2000;37:123–125
  157. Sinico RA, Winearls CG, Sabadini E, et al.  Identification of glomerular immune deposits in cryoglobulinemia glomerulonephritis. Kidney Int. 1988;34:109–116
  158. Sneller MC, Hoffman GS, Talar-Williams C, et al.  An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone. Arthritis Rheum. 1995;38:608–613
  159. Stavrou P, Deutsch J, Rene C, et al.  Ocular manifestations of classical and limited Wegener's granulomatosis. Q J Med. 1993;86:719–725
  160. Stegeman CA, Tervaert JW, de Jong PE, Kallenberg CG. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med. 1996;335:16–20
  161. Stillerman ML. Ocular manifestations of diffuse collagen disease. Arch Ophthalmol. 1951;45:239–250
  162. The vasculitides: immune to subspecialty borders. Curr Opin Rheumatol. 2001;13:1–2
  163. Stone JH, Nousari HC. “Essential” cutaneous vasculitis: what every rheumatologist should know about vasculitis of the skin. Curr Opin Rheumatol. 2001;13:23–34
  164. Straatsma BR. Ocular manifestations of Wegener's granulomatosis. Am J Ophthalmol. 1957;44:789–799
  165. Tanaka T, Shimizu K. Retinal arteriovenous shunts in Takayasu disease. Ophthalmology. 1987;94:1380–1388
  166. Tovilla-Canales JL. Ocular manifestations of giant cell arteritis. Curr Opin Ophthalmol. 1998;9:73–79
  167. Treister G, Machemer R. Results of vitrectomy for rare proliferative and hemorrhagic diseases. Am J Ophthalmol. 1977;84:394–412
  168. Trepo CG, Zucherman AJ, Bird RC, Prince AM. The role of circulating hepatitis B antigen/antibody immune complexes in the pathogenesis of vascular and hepatic manifestations in polyarteritis nodosa. J Clin Pathol. 1974;27:863–868
  169. Tripathy NK, Upadhyaya S, Sinha N, Nityanand S. Complement and cell mediated cytotoxicity by antiendothelial cell antibodies in Takayasu's arteritis. J Rheumatol. 2001;28:805–808
  170. Tsai JC, Forster DJ, Ober RR, Rao NA. Panuveitis and multifocal retinitis in a patient with leucocytoclastic vasculitis. Br J Ophthalmol. 1993;77:318–320
  171. Van Wien S, Merz EH. Exophthalmos secondary to periarteritis nodosa. Am J Ophthalmol. 1963;56:204–208
  172. Watson PG, Hayreh SS. Scleritis and episcleritis. Br J Ophthalmol. 1976;60:163–191
  173. Watts RA, Scott DG, Pusey CD, Lockwood CM. Vasculitis-aims of therapy. An overview. Rheumatology (Oxford). 2000;39:229–232
  174. Weinstein JM, Chui H, Lane S, et al.  Churg-Strauss syndrome (allergic granulomatous angiitis). Neuro-ophthalmologic manifestations. Arch Ophthalmol. 1983;101:1217–1220
  175. Whitfield AG, Bateman M, Cooke WT. Temporal arteritis. Br J Ophthalmol. 1963;47:555–556
  176. Wilkinson IM, Russell RW. Arteries of the head and neck in giant cell arteritis. A pathological study to show the pattern of arterial involvement. Arch Neurol. 1972;27:378–391
  177. Wise GN. Ocular periarteritis nodosa. Report of two cases. Arch Ophthalmol. 1951;45:1–11
  178. Wong RL, Korn JH. Temporal arteritis without an elevated erythrocyte sedimentation rate. Case report and review of the literature. Am J Med. 1986;80:959–964
  179. Yamabe H, Ozawa K, Fukushi K, et al.  IgA nephropathy and Henoch-Schönlein purpura nephritis with anterior uveitis. Nephron. 1988;50:368–370
  180. Yanagawa H, Nakamura Y, Yashiro M, et al.  Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan. Pediatrics. 1998;102:E65
  181. Zaman F, Granville L, Trocme SD. Ocular manifestations of immunologic and rheumatologic inflammatory disorders. Curr Opin Ophthalmol. 1997;8:81–84
  182. Zeek PM. Periarteritis nodosa: a critical review. Am J Clin Pathol. 1952;22:777–790

☆ The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article.

PII: S0039-6257(04)00088-8

doi: 10.1016/j.survophthal.2004.04.008

Survey of Ophthalmology
Volume 49, Issue 4 , Pages 399-418 , July 2004

Article Tools

* Image Usage & Resolution